scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Sequencing technologies-the next generation

01 Jan 2010-Nature Reviews Genetics (Nature Publishing Group)-Vol. 11, Iss: 1, pp 31-46
TL;DR: A technical review of template preparation, sequencing and imaging, genome alignment and assembly approaches, and recent advances in current and near-term commercially available NGS instruments is presented.
Abstract: Demand has never been greater for revolutionary technologies that deliver fast, inexpensive and accurate genome information. This challenge has catalysed the development of next-generation sequencing (NGS) technologies. The inexpensive production of large volumes of sequence data is the primary advantage over conventional methods. Here, I present a technical review of template preparation, sequencing and imaging, genome alignment and assembly approaches, and recent advances in current and near-term commercially available NGS instruments. I also outline the broad range of applications for NGS technologies, in addition to providing guidelines for platform selection to address biological questions of interest.

Summary (1 min read)

Jump to:  and [Summary]

Summary

  • DNA sequencing is one of the most important platforms for study in biological systems today.
  • The high-throughput-next generation sequencing technologies delivers fast, inexpensive, and accurate genome information.
  • Next generation sequencing can produce over 100 times more data than methods based on Sanger Sequencing.
  • The next generation sequencing technologies offered from Illumina / Solexa, ABI/SOLiD, 454/Roche, and Helicos has provided unprecedented opportunity for high-throughput functional genomic research.
  • Next generation sequence technologies offer novel and rapid ways for genome-wide characterization and profiling of mRNA's, transcription factor regions, and DNA patterns.

Did you find this useful? Give us your feedback

Content maybe subject to copyright    Report

TEMPLATE DESIGN © 2008
www.PosterPresentations.com
ABSTRACT
Conclusion and Future Work
Next Generation Sequencing
CONTACT INFO
Data Analysis Comparisons
Downstream Analysis
REFERENCES
DNA sequencing is one of the most important platforms for
study in biological systems today. The high-throughput-next
generation sequencing technologies delivers fast,
inexpensive, and accurate genome information. Next
generation sequencing can produce over 100 times more data
than methods based on Sanger Sequencing. The next
generation sequencing technologies offered from Illumina /
Solexa, ABI/SOLiD, 454/Roche, and Helicos has provided
unprecedented opportunity for high–throughput functional
genomic research. Next generation sequence technologies
offer novel and rapid ways for genome-wide characterization
and profiling of mRNAs, transcription factor regions, and DNA
patterns.
Fig. 7) This is a plot of the frequency of each percentage covered for all nodes.
BLAST is in blue, MUMmer is in green.
Sequencing Technologies – the Next Generation,
Micahel L. Metzkerh
Next Generation Sequencing Pipeline Development and Data Analysis
Fig. 9) This is a plot of the coverage of each Node. BLAST points are blue,
MUMmer points are red.
Fig. 6) This is a plot of the frequency of each percentage covered for all contigs.
BLAST is in blue, MUMmer is in green.
454/Roche – 454 Life Sciences is a Biotechnology company
that is a part of Roche and based in Branford, Connecticut.
The center develops ultra-fast high-throughput DNA
sequencing methods and tools.
Illumina/Solexa– Illumina is a company that develops and
manufactures integrated systems for the analysis of gene
variation. Solexa was founded to develop genome
sequencing technology.
ABI/SOLiD - (Sequencing by Oligonucleotide Ligation and
Detection) is a next-generation DNA sequencing technology
developed by Life Technologies and has been commercially
available since 2006. This next generation technology
generates hundreds of millions to billions of small sequence
reads at one time.
Helicos - Helicos's technology images the extension of
individual DNA molecules using a defined primer and
individual fluorescently labeled nucleotides, which contain a
"virtual terminator" preventing incorporation of multiple
nucleotides per cycle.
Julian Pierre
1
, Jordan Taylor
2
, Amit Upadhyay
3
, Bhanu Rekepalli
3
Fig. 8) This is a plot of the coverage of each Contig. BLAST points are blue,
MUMmer points are red.
Using the coverage of
each individual contig
ID, the results for both
BLAST and MUMmer
were plotted. While
BLAST hit more contigs,
there are more contigs
with a higher coverage
that were hit by
MUMmer.
Using the data gathered
from both BLAST and
MUMmer, the frequency
of the amount covered
for each contig was
plotted. From Fig 6), it
can be inferred that
MUMmer hit more
accurately for contigs.
Fig 4) from main.g2.bx.psu.edu
Once the results were found using both the BLAST and
MUMmer search tools, we created a program to see which
sequencing tool had the most hits per contig. The total
number of contigs in the database file is 160,749 and the
total number of nodes in the query file is 552,305. BLAST
returned a total of 123,070 hits and MUMmer returned a
total of 121,829 hits. From the results, MUMmer hit more
accurately than BLAST while BLAST hit more contigs than
MUMmer.
In Next-Generation Sequencing, data analysis is one of the
most expensive processes. While the cost of genome
sequencing goes down, the cost of analyzing data is still
expensive. In the future, the “$1,000 genome will come with
a $20,000 analysis price tag.”
The same process was
done with the Nodes.
From Fig 7), it can be
inferred that BLAST hit
more accurately with
nodes. However, there
are more BLAST results
with lower coverage.
The future of next generation sequencing can be broken
down into a variety of categories such as personalized
medicine, bio fuels, climate change, and other life science
fields.
Personalized Medicine is a medical model that proposes
the customization of medical decision to tailor an
individual
Bio Fuels present a source of alternative energy.
Microalgal biofuels use algae to synthesize the fuel. In
order to optimize the process, an understanding of the
gene-function relationship of algae would prove helpful.
Climate change is the active study of past and future
theoretical models which uses the past climate data to
make future projections.
In conclusion, we hope to contribute the knowledge we
have gained to contribute to fields such as these.
The same process was
done with the Nodes.
While BLAST hit more
Nodes, there are more
Nodes that hit with a
lower coverage using
BLAST.
1 Texas Southern University, 2 Austin Peay State University, 3 University of Tennessee
Next Gen Sequencing uses a wide array of tools to obtain results based
on the genome sequence. The most widely used Tools are BLAST,
HMMER, and MUMmer.
BLAST (Basic Local Alignment Search Tool) is a multi-sequence
alignment tool developed by NIH (National Institute of Health). It is
used find similar regions in different sequences and then compare
their similarities.
MUMmer (Maximum Unique Matches) is a rapid alignment system
used for rapidly aligning entire genomes. It can also align incomplete
genomes and can easily handle 1000’s of contigs from a shotgun
sequencing project.
HMMER (Hidden Markov Modeler) is used for searching sequence
databases for homologs of protein sequences, and for making protein
sequence alignments. It implements methods using probabilistic
models called profile hidden Markov models (HMMs)
Genome Assembly
Sequence Analysis refers to
the process of subjecting a
DNA, RNA or peptide
sequence to a wide range of
analytical methods to:
Compare sequences to find
similarities and infer if they
are Homologous
To identify the features of
the sequence such as gene
structure, distribution,
introns and exons, and
regulation of gene
expression
Identify Sequence
differences and variations
such as mutations
Fig. 1) This is figure shows three different Next Generation Sequencing methods. [2]
Fig. 2) Taken from A Hitchhiker’s Guide to Next-Generation Sequencing, by Gabe Rudy
Fig. 3) Taken from bio.davidson.edu/courses. Shows alignment results for yeast.
Fig 5) from jcvi.org shows the mapping of chr6 of a Human Genome
Julian Pierre – julz_pierre@yahoo.com
Jordan Taylor – jtaylor74@my.apsu.edu
Amit Upadhyay – aupadhy1@utk.edu
Bhanu Rekepalli – brekapal@utk.edu
http://www.roche.com/research_and_development/r_d_overview/
r_d_sites.htm?id=18
http://www.pnas.org/content/99/6/3712/F1.expansion.html
http://www.yerkes.emory.edu/nhp_genomics_core/Services/
Sequencing.html
http://www.illumina.com/technology/solexa_technology.ilmn
http://blast.ncbi.nlm.nih.gov/Blast.cgi
https://main.g2.bx.psu.edu/u/dan/p/fastq
http://ori.dhhs.gov/education/products/n_illinois_u/datamanagement/
datopic.htmll
http://www.jcvi.org/medicago/include/images/chr6.BamHI.maps.jpg
Gabe Rudy, (2010) A Hitchhikers Guide to Next-Generation
Sequencing, :1-9, Golden Helix
[1] John D. McPherson, (2009) Next-Generation Gap, 6:1-4, Nature
Methods Supplement
[2]Michael L. Metzker, (2010) Sequencing Technologies, - the next
generation, 11:1-5, Nature Reviews
Md. Fakruddin,Khanjada Shahnewaj Bin mannan, (2012) Next
Generation sequencing technologies – Principles and prospects,
6:1-9, Research and Reviews in Biosciences
Misra N., Panda P. K., Parida B. K., Mishra B. K., (2012)
Phylogenomic Study of Lipid Genes Involved in Mocroalgal Biofuel
Production – Candidate Gene Mining and Metabolic Pathway
Analyses, Evolutionary Bioinformatics 8:545-564, doi: 10.4137/
EBO.S10159
Galaxy is an open, web-based
platform for data intensive
biomedical research. It can be
used on its own free public
server where you can perform,
reproduce, and share complete
analyses.
An example of how Galaxy
reflects its data is shown in Fig 5.
Two FASTA files related to the same nucleotide sequence
were input into both BLAST and MUMmer and the results
were parsed into tables. Then, the coverage of all hit contigs
and nodes from both programs was found.
Citations
More filters
Journal ArticleDOI
TL;DR: The different innovative methods to respond to the challenge of characterizing the mode of action for antibacterial natural products have cumulatively built useful frameworks that may advocate a renovated interest in natural product drug discovery programs.

88 citations

Journal ArticleDOI
TL;DR: Recent technological advances in genome-wide DNA methylation analysis are described and their relative utility and drawbacks are discussed, providing specific examples from studies that have used these technologies for genome- wide DNA methylations analysis to address important biological questions.
Abstract: The covalent DNA modification of cytosine at position 5 (5-methylcytosine; 5mC) has emerged as an important epigenetic mark most commonly present in the context of CpG dinucleotides in mammalian cells. In pluripotent stem cells and plants, it is also found in non-CpG and CpNpG contexts, respectively. 5mC has important implications in a diverse set of biological processes, including transcriptional regulation. Aberrant DNA methylation has been shown to be associated with a wide variety of human ailments and thus is the focus of active investigation. Methods used for detecting DNA methylation have revolutionized our understanding of this epigenetic mark and provided new insights into its role in diverse biological functions. Here we describe recent technological advances in genome-wide DNA methylation analysis and discuss their relative utility and drawbacks, providing specific examples from studies that have used these technologies for genome-wide DNA methylation analysis to address important biological questions. Finally, we discuss a newly identified covalent DNA modification, 5-hydroxymethylcytosine (5hmC), and speculate on its possible biological function, as well as describe a new methodology that can distinguish 5hmC from 5mC.

88 citations

Journal ArticleDOI
TL;DR: This study represents one of the first whole-genome sequencing studies in autism leveraging a large family-based pedigree and identifies seven candidate genes shared by the two probands and identifies 33 prioritized non-coding variants such as those near SMG6 and COQ5, based on evolutionary constraint and experimental evidence from ENCODE.
Abstract: Autism spectrum disorders (ASDs) represent a group of childhood neurodevelopmental disorders that affect 1 in 88 children in the US. Previous exome sequencing studies on family trios have implicated a role for rare, de-novo mutations in the pathogenesis of autism. To examine the utility of whole-genome sequencing to identify inherited disease candidate variants and genes, we sequenced two probands from a large pedigree, including two parents and eight children. We evaluated multiple analytical strategies to identify a prioritized list of candidate genes. By assuming a recessive model of inheritance, we identified seven candidate genes shared by the two probands. We also evaluated a different analytical strategy that does not require the assumption of disease model, and identified a list of 59 candidate variants that may increase susceptibility to autism. Manual examination of this list identified ANK3 as the most likely candidate gene. Finally, we identified 33 prioritized non-coding variants such as those near SMG6 and COQ5, based on evolutionary constraint and experimental evidence from ENCODE. Although we were unable to confirm rigorously whether any of these genes indeed contribute to the disease, our analysis provides a prioritized shortlist for further validation studies. Our study represents one of the first whole-genome sequencing studies in autism leveraging a large family-based pedigree. These results provide for a discussion on the relative merits of finding de-novo mutations in sporadic cases versus finding inherited mutations in large pedigrees, in the context of neuropsychiatric and neurodevelopmental diseases.

88 citations


Cites background from "Sequencing technologies-the next ge..."

  • ...Recent genetic studies demonstrated that nextgeneration sequencing (NGS) technology can be a powerful tool to identify the genetic basis of human diseases, especially Mendelian disorders [14-16]....

    [...]

Journal ArticleDOI
14 Nov 2012-PLOS ONE
TL;DR: All four NGS platforms were able to detect minority non-R5 variants at comparable levels suggesting that any NGS-based method can be used to predict HIV-1 coreceptor usage.
Abstract: HIV-1 coreceptor tropism assays are required to rule out the presence of CXCR4-tropic (non-R5) viruses prior treatment with CCR5 antagonists. Phenotypic (e.g., Trofile™, Monogram Biosciences) and genotypic (e.g., population sequencing linked to bioinformatic algorithms) assays are the most widely used. Although several next-generation sequencing (NGS) platforms are available, to date all published deep sequencing HIV-1 tropism studies have used the 454™ Life Sciences/Roche platform. In this study, HIV-1 co-receptor usage was predicted for twelve patients scheduled to start a maraviroc-based antiretroviral regimen. The V3 region of the HIV-1 env gene was sequenced using four NGS platforms: 454™, PacBio® RS (Pacific Biosciences), Illumina®, and Ion Torrent™ (Life Technologies). Cross-platform variation was evaluated, including number of reads, read length and error rates. HIV-1 tropism was inferred using Geno2Pheno, Web PSSM, and the 11/24/25 rule and compared with Trofile™ and virologic response to antiretroviral therapy. Error rates related to insertions/deletions (indels) and nucleotide substitutions introduced by the four NGS platforms were low compared to the actual HIV-1 sequence variation. Each platform detected all major virus variants within the HIV-1 population with similar frequencies. Identification of non-R5 viruses was comparable among the four platforms, with minor differences attributable to the algorithms used to infer HIV-1 tropism. All NGS platforms showed similar concordance with virologic response to the maraviroc-based regimen (75% to 80% range depending on the algorithm used), compared to Trofile (80%) and population sequencing (70%). In conclusion, all four NGS platforms were able to detect minority non-R5 variants at comparable levels suggesting that any NGS-based method can be used to predict HIV-1 coreceptor usage.

88 citations


Cites background from "Sequencing technologies-the next ge..."

  • ...As expected each deep sequencing platform differs in terms of the chemistry, read length, yield, error rate, turn-around time, and overall cost [62,63]....

    [...]

Journal ArticleDOI
TL;DR: It is expected that, based upon long-read and high-fidelity next-generation sequencing technologies, the unbiased analysis will provide a more accurate view of the overall antibody repertoire while the barcoding strategy will facilitate high-resolution analysis of individual antibody families.
Abstract: B-cell repertoire analysis using next-generation sequencing has become a valuable tool for interrogating the genetic record of humoral response to infection However, key obstacles such as low throughput, short read length, high error rate, and undetermined bias of multiplex PCR method have hindered broader application of this technology In this study, we report several technical advances in antibody repertoire sequencing We first demonstrated the ability to sequence antibody variable domains using the Ion Torrent PGM platform As a test case, we analyzed the PGT121 class of antibodies from IAVI donor 17, an HIV-1-infected individual We then obtained "unbiased" antibody repertoires by sequencing the 5'-RACE PCR products of B-cell transcripts from IAVI donor 17 and two HIV-1-uninfected individuals We also quantified the bias of previously published gene-specific primers by comparing the repertoires generated by 5'-RACE PCR and multiplex PCR We further developed a single-molecule barcoding strategy to reduce PCR-based amplification noise Lastly, we evaluated several new PGM technologies in the context of antibody sequencing We expect that, based upon long-read and high-fidelity next-generation sequencing technologies, the unbiased analysis will provide a more accurate view of the overall antibody repertoire while the barcoding strategy will facilitate high-resolution analysis of individual antibody families

88 citations

References
More filters
Journal ArticleDOI
TL;DR: The RNA-Seq approach to transcriptome profiling that uses deep-sequencing technologies provides a far more precise measurement of levels of transcripts and their isoforms than other methods.
Abstract: RNA-Seq is a recently developed approach to transcriptome profiling that uses deep-sequencing technologies. Studies using this method have already altered our view of the extent and complexity of eukaryotic transcriptomes. RNA-Seq also provides a far more precise measurement of levels of transcripts and their isoforms than other methods. This article describes the RNA-Seq approach, the challenges associated with its application, and the advances made so far in characterizing several eukaryote transcriptomes.

11,528 citations


"Sequencing technologies-the next ge..." refers background in this paper

  • ...For example, in gene-expression studies microarrays are now being replaced by seq-based methods , which can identify and quantify rare transcripts without prior knowledge of a particular gene and can provide information regarding alternative splicing and sequence variation in identified gene...

    [...]

Journal ArticleDOI
TL;DR: Velvet represents a new approach to assembly that can leverage very short reads in combination with read pairs to produce useful assemblies and is in close agreement with simulated results without read-pair information.
Abstract: We have developed a new set of algorithms, collectively called "Velvet," to manipulate de Bruijn graphs for genomic sequence assembly. A de Bruijn graph is a compact representation based on short words (k-mers) that is ideal for high coverage, very short read (25-50 bp) data sets. Applying Velvet to very short reads and paired-ends information only, one can produce contigs of significant length, up to 50-kb N50 length in simulations of prokaryotic data and 3-kb N50 on simulated mammalian BACs. When applied to real Solexa data sets without read pairs, Velvet generated contigs of approximately 8 kb in a prokaryote and 2 kb in a mammalian BAC, in close agreement with our simulated results without read-pair information. Velvet represents a new approach to assembly that can leverage very short reads in combination with read pairs to produce useful assemblies.

9,389 citations

Journal ArticleDOI
15 Sep 2005-Nature
TL;DR: A scalable, highly parallel sequencing system with raw throughput significantly greater than that of state-of-the-art capillary electrophoresis instruments with 96% coverage at 99.96% accuracy in one run of the machine is described.
Abstract: The proliferation of large-scale DNA-sequencing projects in recent years has driven a search for alternative methods to reduce time and cost. Here we describe a scalable, highly parallel sequencing system with raw throughput significantly greater than that of state-of-the-art capillary electrophoresis instruments. The apparatus uses a novel fibre-optic slide of individual wells and is able to sequence 25 million bases, at 99% or better accuracy, in one four-hour run. To achieve an approximately 100-fold increase in throughput over current Sanger sequencing technology, we have developed an emulsion method for DNA amplification and an instrument for sequencing by synthesis using a pyrosequencing protocol optimized for solid support and picolitre-scale volumes. Here we show the utility, throughput, accuracy and robustness of this system by shotgun sequencing and de novo assembly of the Mycoplasma genitalium genome with 96% coverage at 99.96% accuracy in one run of the machine.

8,434 citations

Journal ArticleDOI
20 Feb 2009-Cell
TL;DR: This work has revealed unexpected diversity in their biogenesis pathways and the regulatory mechanisms that they access, which has direct implications for fundamental biology as well as disease etiology and treatment.

4,490 citations


"Sequencing technologies-the next ge..." refers background in this paper

  • ...and to elucidate the role of non-coding RNAs in health and diseas...

    [...]

Journal ArticleDOI
20 Feb 2009-Cell
TL;DR: The evolution of long noncoding RNAs and their roles in transcriptional regulation, epigenetic gene regulation, and disease are reviewed.

4,277 citations


"Sequencing technologies-the next ge..." refers background in this paper

  • ...and to elucidate the role of non-coding RNAs in health and diseas...

    [...]